[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 8, Issue 2 (4-2006) ::
J Babol Univ Med Sci. 2006; Volume 8 Back to browse issues page
Assessment of IVIG treatment in children and its complications, Babol, 1999-2004
E Mohammad Zadeh I, A, Atar Zadeh * , A Arzani , A Tamaddoni
Abstract:   (8134 Views)
BACKGROUND AND OBJECTIVE: IVIG is used in patients incapable of producing antibodies and in autoimmune disorders. IVIG infusion rarely causes undesirable reactions due to the speed of infusion. So, this study was performed to determine the indications and complications of IVIG infusion.
METHODS: This descriptive study was performed on 265 patients, hospitalized in Amirkola pediatric hospital, needing IVIG infusions, from October 1999 to June 2004. Data was analyzed by SPSS. T-test, chi square and fisher exact test were used to compare drug complications based on age and speed of infusion in two genders.
FINDINGS: In this research, 265 patients with 871 infusions were studied. One hundred and thirty one patients (49.4%) were male and 134 (50.6%) were female. Two patients (0.7%) had autoimmune hemolytic anemia, one patient (0.3%) had ataxia telangectasia, 9 patients (3.4%) had refractory seizure, 2 patients (0.7%) had guillain-barre syndrome, 83 patients (31.3%) had immune thrombocytopenic purpura, 46 patients (17.3%) had kawasaki, 51 patients (19.2%) had immunodeficiency and 72 patients (27.1%) were premature neonates. Among the studied patients, 17 infusions (1.95%) had complications, which were mild in 14 patients (82.5%), moderate in 2 patients (11.7%) and severe in 1 patient (5.8%). Complication was the same in both genders, and it had a significant difference with the speed of drug infusion (p<0.05).
CONCLUSION: The most common cause of IVIG infusion is immune thrombocytopenic purpura. Complications are usually mild and had relationship with the speed of drug infusion.
Keywords: Immunoglobulin, Kawasaki, Immune thrombocytopenic purpura
Full-Text [PDF 309 kb]   (1885 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/1 | Published: 2014/06/1


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammad Zadeh I, A, Atar Zadeh E, Arzani A, Tamaddoni A. Assessment of IVIG treatment in children and its complications, Babol, 1999-2004. J Babol Univ Med Sci 2006; 8 (2) :32-35
URL: http://jbums.org/article-1-2553-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 8, Issue 2 (4-2006) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.05 seconds with 43 queries by YEKTAWEB 4645